Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26F8E9E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,544
Award facts
- Contract value 100% obligated
- $19,544.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,544.11 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on February 4, 2026, for the supply of Kesimpta 20 mg/0.4 mL pen injections. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award, and is scheduled for ultimate completion on February 5, 2026. Performance will occur at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, which carries a potential value of $999,999,999.00 through December 2031 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
Kesimpta (ofatumumab) is a monoclonal antibody used in the treatment of multiple sclerosis, reflecting the breadth of specialty pharmaceutical products supplied through DLA's medical supply chain. AmerisourceBergen's role as a prime pharmaceutical vendor enables delivery of a wide spectrum of medications across multiple therapeutic domains to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The company's consistent competitive award history and substantial contract portfolio demonstrate its established capability to fulfill critical federal pharmaceutical procurement requirements efficiently.
Quick answers
Who was awarded contract SPE2DR26F8E9E?
SPE2DR26F8E9E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F8E9E worth?
The government has obligated $19,544 on SPE2DR26F8E9E.
Is contract SPE2DR26F8E9E an order under another contract?
Yes. SPE2DR26F8E9E is a delivery order under SPE2DR25D3202, an indefinite delivery contract.
Was contract SPE2DR26F8E9E competed?
The extent of competition for SPE2DR26F8E9E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award